The Expression of Cathepsin D in Breast Ductal Carcinoma in Situ and with Early Invasion

Zhimin Shao
2010-01-01
Abstract:Background and purpose:Cathepsin D(Cath-D) is involved in the proliferation and metastasis of invasive breast cancer.However, its influence on the development of carcinoma in situ is not yet known.This study assessed the expression of protease cathepsin D(Cath-D) in breast ductal carcinoma in situ(DCIS) and early invasion(DCIS-EI) as well as investigated its relationship with known clinicopathologic prognostic factors and breast cancer recurrence.Methods:From Jan.1995 to Dec.2006, a total of 336 patients with DCIS and DCIS-MI that treated surgically were retrospectively studied.Results:The positive rate of Cath-D expression was 71.70% in all cases, 69.2% in DCIS and 73.6% in DCIS-EI.Lymph nodes metastases were observed in 4.15% of all cases in the Cath-D positive group and in 1.66% of all cases in the Cath-D negative group.The expression of Cath-D were closely correlated with mutant p53(P=0.001), slightly correlated with ER expression(P=0.075), and had no significant relationship with PR or Her-2 expression.The expression rate of Cath-D increased in recurrence groups(80%) in comparison with nonrecurrence groups(71.5%).Conclusion:In contrast to the expression of Cath D in invasive breast cancer tissues, Cath D in DCIS and DCIS-EI are not found to be associated with known clinicopathologic prognostic factors.Cath-D may be a prognostic marker for DCIS and DCIS-EI but nevertheless, it is not very distinctive.
What problem does this paper attempt to address?